Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy effect on chronic lymphocytic leukemia - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS3829

Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy effect on chronic lymphocytic leukemia

Analysis of CD19+ selected B cells from CLL patients before and after chemoimmunotherapy regimens of rituximab (R), fludarabine and cyclophosphamide (FC), or RFC. Results provide insight into the molecular mechanisms underlying the beneficial effects of the chemoimmunotherapy regimens.

Organism:: Homo sapiens

Type:: Expression profiling by array, transformed count, 5 agent sets

Platform:: GPL570
Series:: GSE15490
50 Samples

Download data: CEL

DataSet

Accession:: GDS3829

ID:: 3829

PubMed Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Related DataSets for GEO Profiles (Select 69369379) (1)
GEO DataSets
Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy effect on chroni...
Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy effect on chronic lymphocytic leukemia
Accession: GDS3829

GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets